Optimizing management of acute leukemia in community centers and when to refer

Research output: Contribution to journalArticlepeer-review

Abstract

Treatment of acute leukemia has been delivered predominantly in academic and larger leukemia treatment centers with the infrastructure and staff needed to manage patients receiving complex therapeutic regimens and supportive care. However, in recent years, several oral agents and less-myelosuppressive regimens were approved, making it possible for these patients to receive therapy in smaller community hospitals and oncology office practices. In this review, we discuss the optimum community setting, type of patient who can be treated, agents that can be applied, and an appropriate clinical circumstance in which a referral to a tertiary center should be made.

Original languageEnglish (US)
Pages (from-to)123-128
Number of pages6
JournalHematology
Volume20
Issue number1
DOIs
StatePublished - Dec 2020

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Optimizing management of acute leukemia in community centers and when to refer'. Together they form a unique fingerprint.

Cite this